Kenvue Inc (KVUE) Stock Price, Quote & News

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products

Sector: Consumer Defensive

Phone: 908 874 1200

Website: www.kenvue.com

Address:

1 Kenvue Way, Summit, United States

WuTangClam Jun. 5 at 3:14 PM

$SPY rotation !! $KMB $KVUE $PG

1 · Reply

Suite510 Jun. 5 at 11:00 AM

$ABT $JNJ $KVUE $SPX Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' lol 🤠🍿

1 · Reply

Suite510 Jun. 4 at 5:20 PM

$BAYRY $JNJ $KVUE $SPX You ready? 🤠🍿 June 03, 2026 'This Is Their Document': Jury Told J&J Docs Prove Talc Lies Counsel for the families of three women who died of ovarian cancer delivered closing arguments Wednesday in their six-week-long bellwether lawsuit against Johnson & Johnson, telling jurors that decades-old internal documents prove the company hid that its talc was contaminated with asbestos.

1 · Reply

Kylea1 Jun. 3 at 5:01 PM

$KVUE worst takeover in history.

0 · Reply

Suite510 Jun. 2 at 8:12 PM

$BAYRY $JNJ $KVUE Get ready JNJ your up next with 67,000 lawsuits for Talc Cancer Deaths the largest MDL in the USA! Clock is ticking nowhere to hide 🙈 “Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement”

1 · Reply

AStrokeOfLuck May. 29 at 6:36 PM

$KMB $KVUE

0 · Reply

TwelveEggsInOneBasket May. 29 at 4:43 PM

$KVUE my position closes if it ends above 17.5 today. Anything below 17.70 is profit.

0 · Reply

Kylea1 May. 29 at 3:06 AM

$KVUE when’s the buyout closing out?

0 · Reply

CupShaker May. 28 at 12:35 AM

$KVUE such boring pumps and dumps, probably getting out of this borefest, there are better narratives to follow than RFK being a crazy idiot...

0 · Reply

BillionerOfKing May. 26 at 3:57 AM

$KVUE Current Stock Price: $17.55 Contracts to trade: $17.5 KVUE May 29 2026 Call Entry: $0.16 Exit: $0.30 ROI: 88% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW BAX EXP EXPD HPQ IESC

May 21, 2026, 9:00 AM EDT - 15 days ago

Kenvue Transcript: AGM 2026

May 7, 2026, 9:30 AM EDT - 4 weeks ago

Kenvue Earnings release: Q1 2026

May 7, 2026, 9:30 AM EDT - 4 weeks ago

Kenvue Quarterly report: Q1 2026

May 7, 2026, 7:15 AM EDT - 4 weeks ago

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

KMB

2026-05-07T11:12:08.000Z - 4 weeks ago

Kenvue reports Q1 adjusted EPS 32c, consensus 26c

May 7, 2026, 6:30 AM EDT - 4 weeks ago

Kenvue Reports First Quarter 2026 Results

Apr 29, 2026, 6:45 AM EDT - 5 weeks ago

Kenvue Declares Quarterly Cash Dividend

Apr 26, 2026, 9:40 AM EDT - 5 weeks ago

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

CAG CALM FLO KMB NOMD

Apr 23, 2026, 4:32 PM EDT - 6 weeks ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 15, 2026, 10:01 AM EDT - 7 weeks ago

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

KMB

Apr 15, 2026, 9:52 AM EDT - 7 weeks ago

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

KMB

2026-04-15T13:04:56.000Z - 7 weeks ago

Kimberly-Clark announces organizational structure after acquisition of Kenvue

KMB

Apr 15, 2026, 8:55 AM EDT - 7 weeks ago

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

KMB

2026-04-15T10:40:06.000Z - 7 weeks ago

Kenvue price target lowered to $19 from $20 at Citi

2026-04-14T13:08:51.000Z - 7 weeks ago

Kenvue price target lowered to $18 from $19 at Barclays

Apr 13, 2026, 2:09 PM EDT - 7 weeks ago

Tylenol in pregnancy not linked with autism, Danish study finds

Apr 8, 2026, 8:00 AM EDT - 2 months ago

Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 2 months ago

Kenvue Proxy statement: Proxy filing

2026-04-07T11:09:21.000Z - 2 months ago

Kenvue price target lowered to $18 from $19 at UBS

Mar 6, 2026, 12:43 PM EST - 3 months ago

Tylenol use among women dropped after Trump tied it to autism

2026-03-06T10:52:41.000Z - 3 months ago

Kenvue price target raised to $19 from $18 at Barclays

2026-02-26T17:20:12.000Z - 3 months ago

Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports

Feb 26, 2026, 11:14 AM EST - 3 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

2026-02-20T20:31:01.000Z - 3 months ago

Kenvue rumor highlighted in Betaville blog

2026-02-18T12:46:01.000Z - 3 months ago

Kenvue price target raised to $19 from $17 at UBS

2026-02-18T12:17:16.000Z - 3 months ago

Kenvue price target raised to $18 from $17 at Canaccord

2026-02-18T11:35:35.000Z - 3 months ago

Kenvue price target raised to $20 from $18 at Citi

Feb 17, 2026, 5:50 PM EST - 3 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:42 PM EST - 3 months ago

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

KMB

2026-02-17T21:50:45.000Z - 3 months ago

Kenvue reports Q4 EPS 27c, consensus 22c

Feb 17, 2026, 4:45 PM EST - 3 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:00 PM EST - 3 months ago

Kenvue Annual report: Q4 2025

Feb 17, 2026, 4:00 PM EST - 3 months ago

Kenvue Earnings release: Q4 2025

Feb 4, 2026, 6:45 AM EST - 4 months ago

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Jan 29, 2026, 9:27 AM EST - 4 months ago

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

KMB

Jan 29, 2026, 9:00 AM EST - 4 months ago

Kenvue Transcript: AGM 2026

Jan 27, 2026, 6:40 AM EST - 4 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB

Jan 16, 2026, 6:32 PM EST - 4 months ago

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

Jan 16, 2026, 10:00 AM EST - 5 months ago

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

KMB

Dec 16, 2025, 7:00 AM EST - 6 months ago

Kenvue Proxy statement: Proxy Filing

Nov 17, 2025, 6:07 AM EST - 7 months ago

US appeals court to weigh reviving cases over Tylenol and autism

Nov 14, 2025, 12:42 PM EST - 7 months ago

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Nov 14, 2025, 6:05 AM EST - 7 months ago

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Nov 6, 2025, 8:06 AM EST - 7 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 3, 2025, 10:00 PM EST - 7 months ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KMB

Nov 3, 2025, 7:11 PM EST - 7 months ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KMB

Nov 3, 2025, 6:40 PM EST - 7 months ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KMB

Nov 3, 2025, 5:20 PM EST - 7 months ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KMB

Nov 3, 2025, 5:15 PM EST - 7 months ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KMB

Nov 3, 2025, 4:58 PM EST - 7 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KMB

Nov 3, 2025, 4:39 PM EST - 7 months ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KMB

Nov 3, 2025, 4:01 PM EST - 7 months ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KMB

Nov 3, 2025, 3:29 PM EST - 7 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB

Nov 3, 2025, 12:37 PM EST - 7 months ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KMB

Nov 3, 2025, 12:01 PM EST - 7 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KMB

Nov 3, 2025, 11:40 AM EST - 7 months ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KMB

Nov 3, 2025, 11:18 AM EST - 7 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB

Nov 3, 2025, 10:44 AM EST - 7 months ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KMB

Nov 3, 2025, 10:33 AM EST - 7 months ago

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

KMB

Nov 3, 2025, 9:57 AM EST - 7 months ago

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

KMB

Nov 3, 2025, 9:30 AM EST - 7 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:16 AM EST - 7 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

KMB

Nov 3, 2025, 9:15 AM EST - 7 months ago

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

KMB

Nov 3, 2025, 8:40 AM EST - 7 months ago

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

KMB

Nov 3, 2025, 8:27 AM EST - 7 months ago

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

KMB

Nov 3, 2025, 8:24 AM EST - 7 months ago

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

KMB

WuTangClam Jun. 5 at 3:14 PM

$SPY rotation !! $KMB $KVUE $PG

1 · Reply

Suite510 Jun. 5 at 11:00 AM

$ABT $JNJ $KVUE $SPX Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' lol 🤠🍿

1 · Reply

Suite510 Jun. 4 at 5:20 PM

1 · Reply

Kylea1 Jun. 3 at 5:01 PM

$KVUE worst takeover in history.

0 · Reply

Suite510 Jun. 2 at 8:12 PM

1 · Reply

AStrokeOfLuck May. 29 at 6:36 PM

$KMB $KVUE

0 · Reply

TwelveEggsInOneBasket May. 29 at 4:43 PM

$KVUE my position closes if it ends above 17.5 today. Anything below 17.70 is profit.

0 · Reply

Kylea1 May. 29 at 3:06 AM

$KVUE when’s the buyout closing out?

0 · Reply

CupShaker May. 28 at 12:35 AM

$KVUE such boring pumps and dumps, probably getting out of this borefest, there are better narratives to follow than RFK being a crazy idiot...

0 · Reply

BillionerOfKing May. 26 at 3:57 AM

0 · Reply

CapitalMonk May. 25 at 5:50 PM

$KVUE Price: $17.53 (+0.40%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.85% RSI: 64.4 | Momentum: Moderate Volume: -33.9% vs avg Volatility: 1.16% Support: $16.81 | Resistance: $17.68 Sourch: http://marketbaubles.com/

0 · Reply

Suite510 May. 25 at 2:54 AM

$ABT $JNJ $KVUE $SPX lol 😂 zzzzzz asleep at the wheel The jury verdict resulted in a significant personal injury award for the plaintiff, expanding the scope of talc related legal exposure for the company. This case adds to Johnson & Johnson’s ongoing talc litigation and raises fresh questions about future legal and reputational risk.

2 · Reply

Suite510 May. 23 at 11:22 AM

$JNJ $KVUE $SPX $ABT You can’t play legal games and fake bankruptcies forever 😂🍔 J&J's 'Pure' Baby Powder Ads Were Pure Lies, Jury Told A University of Toronto marketing professor on Friday told a Los Angeles jury considering bellwether claims that Johnson & Johnson's talc products caused deadly ovarian cancer in three women that the company advertised its talc as "pure" and safe even though its leaders fretted for decades that it could health risks.

0 · Reply

TonyG6ix May. 23 at 12:38 AM

$KVUE couple of short puts expiring, jeez when is this buyout going to close. I want to start trading my $KMB shares.

0 · Reply

Suite510 May. 22 at 12:22 PM

$ABT $JNJ $KVUE $SPX oh boy Jury Awards $10.2M Verdict in Case Tying Cancer to Asbestos-Laced Talc A 43-year-old man claimed a lifelong use of talc products led to his illness and a Minnesota jury agreed, awarding him and his wife $10.2M

1 · Reply

Suite510 May. 22 at 11:40 AM

$JNJ $KVUE $SPX $ABT Can’t say i didn’t give you a heads up on this 😂 “JNJ Used Ellipsis To Nix Asbestos In Report To FDA, Jury Told”

0 · Reply

CapitalMonk May. 21 at 6:04 PM

$KVUE Price: $17.51 (+1.13%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.09% RSI: 56.4 | Momentum: Moderate Volume: -50.3% vs avg Volatility: 1.17% Support: $16.81 | Resistance: $17.68 Sourch: http://marketbaubles.com/

0 · Reply

Blockwave1 May. 18 at 1:47 PM

HIGH CONFIDENCE🚨 $KVUE 22 MAY 26 $17.5 CALL $0.14

0 · Reply

CaesarZane May. 15 at 9:25 PM

$KVUE $AMD $MSFT 🚀🚀🚀 https://youtu.be/erlo8-MHc1Q

0 · Reply

Bazzzigar May. 15 at 6:09 PM

$KVUE more drop ahead

0 · Reply

Suite510 May. 15 at 4:29 PM

$ABT $JNJ $KVUE $SPX JNJ is a ticking bomb, 30B to 50B talc liability upcoming, there getting slammed in LA Court this week 😂 66,000 plaintiffs will finally get there justice after years of delays May 14, 2026 Human Reproduction Proves Talc Can Reach Ovaries, Jury Told A medical oncologist on Thursday told a Los Angeles bellwether jury considering claims that Johnson & Johnson's talc products caused three women's deadly ovarian cancer that the female reproductive system is an "open" system where talc can migrate to the ovaries, and that "we wouldn't exist" if that was not!

1 · Reply

Bazzzigar May. 13 at 7:17 PM

$KVUE TSCO

0 · Reply

Market Cap	32.31B
Revenue (ttm)	15.12B
Net Income (ttm)	1.47B
EPS (ttm)	N/A
PE Ratio	14.93
Forward PE	14.94
Profit Margin	9.72%
Debt to Equity Ratio	0.67

Volume	13,406,565
Avg Vol	19,686,404
Day's Range	N/A - N/A
Shares Out	1.92B
Stochastic %K	16%
Beta	0.54
Analysts	Sell
Price Target	$19.00